A man with ALS received a Neuralink BCI implant, allowing him to control a laptop cursor and generate his own voice using AI.

The global amyotrophic lateral sclerosis market is on an upward trajectory, demonstrating significant potential for growth and innovation. According to the latest insights from Future Market Insights ...

Brad Smith, who is the first person with ALS and third to receive a Neuralink brain implant, shared his experience with the ...

Advocates for patients with amyotrophic lateral sclerosis — a fatal condition known as Lou Gehrig’s disease — urged lawmakers ...

Amyotrophic lateral sclerosis (ALS) is a disease that destroys the nerves necessary for movement. About 30,000 people in the ...

The Brigance Brigade Foundation held its 13th annual walk/run fundraiser at the Maryland Zoo Saturday, raising awareness and ...

Students from the University of South Carolina started a recent campaign using the ice bucket challenge to raise mental health awareness. The repurposing of the trend has sparked criticism from people ...

Boston College baseball lost the third game of its series against Miami at Fenway Park on Sunday in the annual ALS Awareness ...

The Eagle-Tribune interviewed Charles “Chuck” Johnson and Nicole Johnson on April 11 for a story to show how the North ...

Abnormal kinase signaling can promote other harmful traits, such as neuroinflammation and neuronal cell death. On the other hand, the loss of function in certain kinases has been identified as a ...

Prilenia Therapeutics has entered into a collaboration & license agreement with Ferrer for the commercialization and further development of pridopidine in Europe and other select markets.

Coya Therapeutics sees success in early COYA-302 FTD trial, aims for Phase 2b in H2 2025 and ALS filing in Q2 2025. Read why ...